Background: The prevalence of diabetes mellitus in India is alarmingly high despite availability of several therapeutic agents. Thus, the current study was conducted to understand the role of Ayurveda based Comprehensive Diabetes Care (CDC) program in the management of type 2 diabetes mellitus.
Methods: A retrospective, observational study was conducted from January 2014 to September 2022 at Madhavbaug Clinic, Maharashtra. Patients aged 18 years and above with a diagnosis of type 2 diabetes mellitus according to the American Diabetes Association (ADA) with body mass index >25 participated in the CDC program and were included in this study. Follow-up was conducted after 90 days. Baseline data was compared with follow-up data.
Results: A total of 63 patients were assessed. Of the male patients, 29.3%, 43.9%, and 26.8% were found to have impaired, negative and positive glucose tolerance. Among the females, 22.7%, 63.6%, and 13.6% were found to be have impaired, negative and positive glucose tolerance. Weight decreased from 70.70 ± 9.82 kg to 65.15 ± 9.83 kg (p<0.001) from day 1 to day 90. Body mass index decreased from 27.00 ± 3.88 to 24.91 ± 3.75 (p<0.001) from day 1 to day 90. Glycated haemoglobin (HbA1c) decreased from 7.87 ± 1.90% to 5.79 ± 0.51% (p<0.001) from day 1 to day 90.
Conclusion: Remission of type 2 diabetes mellitus in obese patients is possible with Ayurvedic principles and diet compliance.